During the last session, RXO Inc (NYSE:RXO)’s traded shares were 1.56 million, with the beta value of the company hitting 1.46. At the end of the trading day, the stock’s price was $20.43, reflecting an intraday gain of 1.59% or $0.32. The 52-week high for the RXO share is $32.82, that puts it down -60.65 from that peak though still a striking 8.22% gain since the share price plummeted to a 52-week low of $18.75. The company’s market capitalization is $3.34B, and the average trade volume was 1.23 million shares over the past three months.
RXO Inc (RXO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.95. RXO has a Sell rating from 3 analyst(s) out of 25 analysts who have looked at this stock. 8 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 13 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.01.
RXO Inc (NYSE:RXO) trade information
RXO Inc (RXO) registered a 1.59% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.59% in intraday trading to $20.43, hitting a weekly high. The stock’s 5-day price performance is 2.92%, and it has moved by -17.09% in 30 days. Based on these gigs, the overall price performance for the year is -3.18%.
The consensus price target of analysts on Wall Street is $30, which implies an increase of 31.9% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $16 and $33 respectively. As a result, RXO is trading at a discount of -61.53% off the target high and 21.68% off the low.
RXO Inc (RXO) estimates and forecasts
In the rating firms’ projections, revenue will increase 45.60% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 1.51B as predicted by 15 analyst(s). Meanwhile, a consensus of 15 analyst(s) estimates revenue growth to 1.6B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 913M and 930M respectively. In this case, analysts expect current quarter sales to grow by 65.82% and then jump by 71.53% in the coming quarter.
While earnings are projected to return 146.50% in 2025, the next five years will return 105.41% per annum.
RXO Dividends
RXO Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 17.79 million shares, is of ORBIS ALLAN GRAY LTD’s that is approximately 15.1266% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $465.1 million.
Also, the Mutual Funds coming in first place with the largest holdings of RXO Inc (RXO) shares are iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund . Data provided on Dec 31, 2024 indicates that iShares Core S&P Smallcap ETF owns about 9.03 shares. This amounts to just over 5.53 percent of the company’s overall shares, with a $184.4 million market value. The same data shows that the other fund manager holds slightly less at 4.34, or about 2.66% of the stock, which is worth about $88.72 million.
